Status:
UNKNOWN
Cystoscopy Plus Urethral Dilatation Versus Cystoscopy Alone in Women With Overactive Bladder Syndrome and Impaired Voiding
Lead Sponsor:
Medway NHS Foundation Trust
Conditions:
Overactive Bladder Syndrome
Voiding Dysfunction
Eligibility:
FEMALE
Phase:
NA
Brief Summary
Urethral dilatation is a commonly undertaken intervention for a variety of urinary complaints including overactive bladder symptoms. There is however very little evidence for its efficacy, and no rand...
Detailed Description
This study is a randomised controlled trial. Objective outcomes will be evaluated at 6 weeks' post-operatively. Subjective outcomes will be evaluated at 6 weeks' and 6 months' post-operatively. Study...
Eligibility Criteria
Inclusion
- OAB symptoms (based on relevant domains of BFLUTS questionnaire and Urgency Perception Scale) which have not improved with 2 anticholinergic treatments.
- Maximum flow rate of less than 15 ml/s on a volume voided of 200mls or more, with a normal or high detrusor pressure at maximum flow on pressure flow studies
- Patients must be able to give informed consent for the study
Exclusion
- Presence of concurrent urodynamic stress incontinence
- Patient unfit or unwilling to undergo a general anaesthetic
- Patients with bladder pathology or haematuria of unknown origin
- Patients with neurological disorders (as these may affect voiding)
Key Trial Info
Start Date :
January 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2009
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT00839969
Start Date
January 1 2009
End Date
October 1 2009
Last Update
February 10 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Medway Maritime Hospital
Gillingham, Kent, United Kingdom, ME7 5NY